array:19 [
  "pii" => "X0211699500025525"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2000-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2000;20 Supl 1:60"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1505
    "formatos" => array:3 [
      "EPUB" => 145
      "HTML" => 1098
      "PDF" => 262
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699500025517"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:61-2"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2385
      "formatos" => array:3 [
        "EPUB" => 149
        "HTML" => 1500
        "PDF" => 736
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "«NEFROPATÍA ISQUÉMICA. HIPERALDOSTERONISMO PRIMARIO» Nefropatía isquémica. Definición y epidemiología"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "61"
          "paginaFinal" => "62"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "R. MARÍN"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "R. MARÍN"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025517?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025517/v0_201502091333/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699500025533"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:59"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1429
      "formatos" => array:3 [
        "EPUB" => 156
        "HTML" => 988
        "PDF" => 285
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "The renoprotective actions of angiotensin converting enzyme inhibitors in non diabetic proteinuric nephropathies"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "59"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "P. RUGGENENTI"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "P. RUGGENENTI"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025533?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025533/v0_201502091333/en/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "The Controversies of Hyperuricemia And its Role in Renal Disease and Hypertension"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "60"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "R. J. JOHNSON"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "R. J. JOHNSON"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XX. Suplemento 1. 2000 The Controversies of Hyperuricemia And its Role in Renal Disease and Hypertension R. J. Johnson University of Washington. USA. An elevated uric acid is common in patients with cardiovascular disease and/or hypertension, but rarely is it used in the evaluation or management of patients. In this session, we will review the epidemiology, physiology, potential toxicity and proposed management of hyperuricemia in the hypertensive patient. We will review the data examining the relationship of hyperuricemia to hypertension, coronary artery disease and cardiovascular mortality, including recent data from the NHANES I worksite and SHEP trials. We will then discuss the pathogenesis of the hyperuricemia, which is primarily due to decreased renal excretion secondary to an increase in net tubular reabsorption. We will then discuss the great controversy of whether hyperuricemia represents a true mediator of cardiovascular disease, or whether it is simply a marker for other associated cardiovascular risk factors. If uric acid is a mediator of cardiovascular disease, one of the most likely sites for injury is the kidney, where intrarenal uric acid crystalline deposition is frequently associated with tubulonintestinal damage and hypertension. We will present some experimental data examining the crystalline and noncrystalline effects of uric acid in the kidney. Finally, we will discuss the evidence as to whether uric acid lowering drugs can benefit the renal damage. While clearly more studies are necessary to examine the role of hyperuricemia in cardiovascular disease, we will end the session by providing suggested guidelines for the management of the hypertensive patient with hyperuricemia. 60 "
    "pdfFichero" => "P7-E170-S140-A1902.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025525/v0_201502091333/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35407"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Suplementos"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000020000000S1/v0_201502091333/X0211699500025525/v0_201502091333/en/P7-E170-S140-A1902.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025525?idApp=UINPBA000064"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

The Controversies of Hyperuricemia And its Role in Renal Disease and Hypertension
R. J. JOHNSON
Leído
4479
Veces
se ha leído el artículo
1465
Total PDF
3014
Total HTML
Compartir estadísticas
 array:19 [
  "pii" => "X0211699500025525"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2000-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2000;20 Supl 1:60"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1505
    "formatos" => array:3 [
      "EPUB" => 145
      "HTML" => 1098
      "PDF" => 262
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699500025517"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:61-2"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2385
      "formatos" => array:3 [
        "EPUB" => 149
        "HTML" => 1500
        "PDF" => 736
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "«NEFROPATÍA ISQUÉMICA. HIPERALDOSTERONISMO PRIMARIO» Nefropatía isquémica. Definición y epidemiología"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "61"
          "paginaFinal" => "62"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "R. MARÍN"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "R. MARÍN"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025517?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025517/v0_201502091333/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699500025533"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:59"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1429
      "formatos" => array:3 [
        "EPUB" => 156
        "HTML" => 988
        "PDF" => 285
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "The renoprotective actions of angiotensin converting enzyme inhibitors in non diabetic proteinuric nephropathies"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "59"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "P. RUGGENENTI"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "P. RUGGENENTI"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025533?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025533/v0_201502091333/en/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "The Controversies of Hyperuricemia And its Role in Renal Disease and Hypertension"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "60"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "R. J. JOHNSON"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "R. J. JOHNSON"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XX. Suplemento 1. 2000 The Controversies of Hyperuricemia And its Role in Renal Disease and Hypertension R. J. Johnson University of Washington. USA. An elevated uric acid is common in patients with cardiovascular disease and/or hypertension, but rarely is it used in the evaluation or management of patients. In this session, we will review the epidemiology, physiology, potential toxicity and proposed management of hyperuricemia in the hypertensive patient. We will review the data examining the relationship of hyperuricemia to hypertension, coronary artery disease and cardiovascular mortality, including recent data from the NHANES I worksite and SHEP trials. We will then discuss the pathogenesis of the hyperuricemia, which is primarily due to decreased renal excretion secondary to an increase in net tubular reabsorption. We will then discuss the great controversy of whether hyperuricemia represents a true mediator of cardiovascular disease, or whether it is simply a marker for other associated cardiovascular risk factors. If uric acid is a mediator of cardiovascular disease, one of the most likely sites for injury is the kidney, where intrarenal uric acid crystalline deposition is frequently associated with tubulonintestinal damage and hypertension. We will present some experimental data examining the crystalline and noncrystalline effects of uric acid in the kidney. Finally, we will discuss the evidence as to whether uric acid lowering drugs can benefit the renal damage. While clearly more studies are necessary to examine the role of hyperuricemia in cardiovascular disease, we will end the session by providing suggested guidelines for the management of the hypertensive patient with hyperuricemia. 60 "
    "pdfFichero" => "P7-E170-S140-A1902.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025525/v0_201502091333/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35407"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Suplementos"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000020000000S1/v0_201502091333/X0211699500025525/v0_201502091333/en/P7-E170-S140-A1902.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025525?idApp=UINPBA000064"
]
Información del artículo
ISSN: 02116995
Idioma original: Inglés
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 9 11 20
2024 Octubre 30 28 58
2024 Septiembre 25 20 45
2024 Agosto 36 48 84
2024 Julio 31 42 73
2024 Junio 48 26 74
2024 Mayo 39 32 71
2024 Abril 27 24 51
2024 Marzo 24 26 50
2024 Febrero 30 32 62
2024 Enero 14 26 40
2023 Diciembre 22 27 49
2023 Noviembre 69 30 99
2023 Octubre 47 24 71
2023 Septiembre 36 18 54
2023 Agosto 53 26 79
2023 Julio 40 27 67
2023 Junio 47 12 59
2023 Mayo 57 28 85
2023 Abril 30 15 45
2023 Marzo 27 18 45
2023 Febrero 21 17 38
2023 Enero 21 13 34
2022 Diciembre 19 20 39
2022 Noviembre 24 20 44
2022 Octubre 29 37 66
2022 Septiembre 19 16 35
2022 Agosto 27 36 63
2022 Julio 54 29 83
2022 Junio 47 30 77
2022 Mayo 45 25 70
2022 Abril 54 39 93
2022 Marzo 48 33 81
2022 Febrero 56 24 80
2022 Enero 54 25 79
2021 Diciembre 42 29 71
2021 Noviembre 49 24 73
2021 Octubre 54 34 88
2021 Septiembre 30 17 47
2021 Agosto 46 19 65
2021 Julio 24 30 54
2021 Junio 14 12 26
2021 Mayo 23 14 37
2021 Abril 75 30 105
2021 Marzo 50 7 57
2021 Febrero 27 9 36
2021 Enero 20 11 31
2020 Diciembre 31 7 38
2020 Noviembre 24 5 29
2020 Octubre 22 2 24
2020 Septiembre 13 3 16
2020 Agosto 24 6 30
2020 Julio 13 6 19
2020 Junio 19 5 24
2020 Mayo 13 9 22
2020 Abril 24 8 32
2020 Marzo 8 8 16
2020 Febrero 21 7 28
2020 Enero 28 8 36
2019 Diciembre 11 6 17
2019 Noviembre 8 2 10
2019 Octubre 10 1 11
2019 Septiembre 12 19 31
2019 Agosto 10 5 15
2019 Julio 6 8 14
2019 Junio 8 6 14
2019 Mayo 7 21 28
2019 Abril 33 21 54
2019 Marzo 13 9 22
2019 Febrero 5 13 18
2019 Enero 6 4 10
2018 Diciembre 20 18 38
2018 Noviembre 19 7 26
2018 Octubre 19 3 22
2018 Septiembre 21 17 38
2018 Agosto 15 5 20
2018 Julio 14 6 20
2018 Junio 14 8 22
2018 Mayo 18 7 25
2018 Abril 18 3 21
2018 Marzo 13 5 18
2018 Febrero 15 3 18
2018 Enero 9 4 13
2017 Diciembre 13 5 18
2017 Noviembre 16 4 20
2017 Octubre 11 4 15
2017 Septiembre 6 2 8
2017 Agosto 20 8 28
2017 Julio 14 4 18
2017 Junio 14 4 18
2017 Mayo 7 0 7
2017 Abril 7 1 8
2017 Marzo 6 1 7
2017 Febrero 7 2 9
2017 Enero 9 5 14
2016 Diciembre 12 2 14
2016 Noviembre 20 2 22
2016 Octubre 26 2 28
2016 Septiembre 33 3 36
2016 Agosto 83 1 84
2016 Julio 80 0 80
2016 Junio 55 0 55
2016 Mayo 42 0 42
2016 Abril 16 0 16
2016 Marzo 24 0 24
2016 Febrero 28 0 28
2016 Enero 18 0 18
2015 Diciembre 38 0 38
2015 Noviembre 17 0 17
2015 Octubre 26 0 26
2015 Septiembre 29 0 29
2015 Agosto 19 0 19
2015 Julio 19 0 19
2015 Junio 9 0 9
2015 Mayo 13 0 13
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Nefrología
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?